EYECYTE
EyeCyte, Inc. is working with Pfizer's Bioinnovation and io therapeutics Center and The Scripps Research Institute to develop novel therapeutics to treat neovascular and degenerative retinal disease.
EYECYTE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.eyecyte.com
Total Employee:
1+
Status:
Active
Contact:
858-453-5800
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Aegerion Pharmaceuticals
Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.
American Biogenetic Sciences
American Biogenetic Sciences is the development of diagnostic tests for the detection of cardiovascular and infectious disease
BMdr
BMdr is engaged in the research and development of therapeutics and products for the treatment and prevention of eye diseases.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Sarentis Therapeutics
Sarentis Therapeutics engages in the development of therapeutics for the treatment of pain.
Current Employees Featured
Founder
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - EyeCyte
Official Site Inspections
http://www.eyecyte.com
- Host name: 45.42.41.25
- IP address: 45.42.41.25
- Location: McHenry United States
- Latitude: 42.3275
- Longitude: -88.2918
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60050
More informations about "EyeCyte"
EyeCyte - Crunchbase Company Profile & Funding
Organization. EyeCyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. EyeCyte is engaged …See details»
My EyeCyte Doctor Near Me - EyeCyte
EyeCyte offers amniotic membrane for dry eye therapy on ocular surface for chronic dry eye, scratched cornea treatment, cornea tears, ocular amniotic membrane contact lens for chlamydial conjunctivitis in eye infections , atopic …See details»
EyeCyte, Inc. Secures Series A Funding from Pfizer
Jun 22, 2008 “EyeCyte is delighted to have attracted Pfizer as an investment partner”, said Mohammad A. El-Kalay, Ph.D., president and Chief Executive Officer, EyeCyte. “We are very …See details»
EyeCyte - Products, Competitors, Financials, Employees, …
EyeCyte primarily serves the healthcare industry, connecting consumers and medical professionals with advanced ocular treatment solutions. It is based in La Jolla, California. …See details»
EyeCyte - Funding, Financials, Valuation & Investors - Crunchbase
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases. New. Resources. Advanced Search. ... How much funding has …See details»
Team - EyeCyte
Our Team Our team is here for you ! Leadership Trained to serve, heart to care and passion to change the world our leadership team believes in A RISING TIDE LIFTS ALL BOATS …See details»
EyeCyte - Org Chart, Teams, Culture & Jobs | The Org
View EyeCyte's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
EyeCyte - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 26, 2025 EyeCyte is an early stage biotechnology company which develops novel therapeutics to treat neovascular and degenerative retinal disease. It provides EC200, a cell …See details»
EyeCyte - Crunchbase
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.See details»
Pfizer Funds New Company for the Development of New Stem …
The company Pfizer is funding the creation of a new biotech company in San Diego called EyeCyte, specifically for the development of a new type of adult stem cell therapy that is …See details»
EyeCyte - Overview, News & Similar companies | ZoomInfo.com
EyeCyte will seek to translate these pre-clinical observations into the clinic by engineering a cGMP process to commercialize cell-based therapies for ophthalmic disease. Dr. El-Kalay and …See details»
EyeCyte Obtains $3M from Pfizer through Series A Round
Jun 23, 2008 EyeCyte secured a $3 million series A financing through an agreement with Pfizer. The backing will reportedly support the company into 2010. EyeCyte focuses on …See details»
EyeCyte, Inc. Secures Series A Funding from Pfizer
Jun 24, 2008 Under the terms of the deal, Pfizer has invested $3 million in Series A Preferred shares of EyeCyte. Pfizer will be the sole pharmaceutical partner and will have an Advisory …See details»
Doctors - EyeCyte
Welcome to EyeCyte Welcome to the Future OF OCULAR CARE! OUR TECHNOLOGY, PRODUCTS, TRAINING, NATIONAL BRANDING WITH YOUR EXPERTISE CAN CHANGE …See details»
Eyecyte Research by SuperAGI
```report ## Introduction EyeCyte is a pioneering company specializing in ocular healthcare, particularly focusing on amniotic membrane therapies for the treatment of various eye …See details»
EyeCyte - Contacts, Employees, Board Members, Advisors & Alumni
Organization. EyeCyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. EyeCyte has 1 …See details»
Pfizer bankrolls a stem cell start-up | Fierce Biotech
Jun 24, 2008 And the new company, EyeCyte, will be responsible for advancing that research into the clinic. Pfizer is investing $3 million in the company and has an option to buy it if …See details»
EyeCyte, Inc. Secures Series A Funding From Pfizer
Jun 24, 2008 “ EyeCyte is delighted to have attracted Pfizer as an investment partner ” ... and believe that Pfizer shares our goal of building a premier ophthalmology research and …See details»
Pfizer to invest in adult stem-cell treatment for eyes
Jun 25, 2008 EyeCyte will receive about $3 million from Pfizer, which in return has the right of first refusal regarding the new company’s products. In animal experiments, adult stem-cells …See details»
EyeCyte - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. EyeCyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Total Products Active 14. ... EyeCyte is …See details»